Simplex Trading’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $20K | Sell |
100
-2,900
| -97% | -$574K | ﹤0.01% | 6788 |
|
|
2025
Q4 | $567K | Buy |
+3,000
| New | +$576K | ﹤0.01% | 3176 |
|
|
2025
Q1 | – | Sell |
-100
| Closed | -$10K | – | 9130 |
|
|
2024
Q4 | $10K | Buy |
+100
| New | +$11.3K | ﹤0.01% | 7195 |
|
|
2024
Q3 | – | Sell |
-100
| Closed | -$8K | – | 9073 |
|
|
2024
Q2 | $8K | Sell |
100
-1,300
| -93% | -$103K | ﹤0.01% | 7588 |
|
|
2024
Q1 | $102K | Hold |
1,400
| – | – | ﹤0.01% | 5548 |
|
|
2023
Q4 | $99K | Buy |
+1,400
| New | +$82.6K | ﹤0.01% | 5401 |
|
|
2023
Q3 | – | Sell |
-1,400
| Closed | -$100K | – | 9290 |
|
|
2023
Q2 | $100K | Buy |
+1,400
| New | +$105K | ﹤0.01% | 5079 |
|
|
2022
Q4 | – | Sell |
-802
| Closed | -$43K | – | 9847 |
|
|
2022
Q3 | $43K | Sell |
802
-641
| -44% | -$37.7K | ﹤0.01% | 6643 |
|
|
2022
Q2 | $80K | Sell |
1,443
-320
| -18% | -$18.2K | ﹤0.01% | 5867 |
|
|
2022
Q1 | $123K | Sell |
1,763
-1,283
| -42% | -$93.1K | ﹤0.01% | 5852 |
|
|
2021
Q4 | $293K | Buy |
3,046
+962
| +46% | +$88.9K | ﹤0.01% | 4605 |
|
|
2021
Q3 | $176K | Hold |
2,084
| – | – | ﹤0.01% | 5812 |
|
|
2021
Q2 | $170K | Buy |
2,084
+2,013
| +2,835% | +$167K | ﹤0.01% | 5949 |
|
|
2021
Q1 | $670K | Sell |
71
-40
| -36% | -$3.78K | ﹤0.01% | 2934 |
|
|
2020
Q4 | $686K | Buy |
111
+18
| +19% | +$1.03K | ﹤0.01% | 3038 |
|
|
2020
Q3 | $552K | Sell |
93
-348
| -79% | -$23.7K | ﹤0.01% | 2864 |
|
|
2020
Q2 | $3.08M | Buy |
441
+340
| +337% | +$21.6K | ﹤0.01% | 1175 |
|
|
2020
Q1 | $458K | Sell |
101
-351
| -78% | -$19.9K | ﹤0.01% | 2691 |
|
|
2019
Q4 | $2.94M | Buy |
452
+27
| +6% | +$1.8K | 0.01% | 1175 |
|
|
2019
Q3 | $2.64M | Buy |
425
+375
| +750% | +$23.5K | 0.01% | 1115 |
|
|
2019
Q2 | $353K | Sell |
50
-287
| -85% | -$21.1K | ﹤0.01% | 2911 |
|
|
2019
Q1 | $2.64M | Buy |
337
+233
| +224% | +$17.7K | 0.01% | 1129 |
|
|
2018
Q4 | $882K | Buy |
104
+66
| +174% | +$7.04K | ﹤0.01% | 1728 |
|
|
2018
Q3 | $658K | Sell |
38
-69
| -64% | -$10.4K | ﹤0.01% | 2326 |
|
|
2018
Q2 | $1.39M | Buy |
107
+77
| +257% | +$8.59K | 0.01% | 1460 |
|
|
2018
Q1 | $5K | Buy |
+30
| New | +$2.97K | ﹤0.01% | 4646 |
|
|
2017
Q2 | – | Sell |
-297
| Closed | -$43K | – | 6470 |
|
|
2017
Q1 | $43K | Buy |
297
+158
| +114% | +$10.4K | ﹤0.01% | 2511 |
|
|
2016
Q4 | $35K | Buy |
139
+19
| +16% | +$1.2K | ﹤0.01% | 2503 |
|
|
2016
Q3 | $75K | Buy |
120
+21
| +21% | +$1.54K | 0.01% | 1769 |
|
|
2016
Q2 | $45K | Buy |
99
+94
| +1,880% | +$6.98K | ﹤0.01% | 2166 |
|
|
2016
Q1 | $1K | Buy |
+5
| New | +$304 | ﹤0.01% | 5144 |
|
|
2015
Q4 | – | Sell |
-16
| Closed | -$8K | – | 5786 |
|
|
2015
Q3 | $8K | Buy |
+16
| New | +$971 | ﹤0.01% | 3639 |
|
|
2015
Q2 | – | Sell |
-40
| Closed | -$4K | – | 5533 |
|
|
2015
Q1 | $4K | Buy |
40
+34
| +567% | +$1.3K | ﹤0.01% | 3680 |
|
|
2014
Q4 | $1K | Buy |
+6
| New | +$195 | ﹤0.01% | 4165 |
|
Other funds holding LGND
VPM
VCM
NAMI
CC
Simplex Trading's LGND Position: Q1 2026 in Review
Simplex Trading sold out of Ligand Pharmaceuticals (LGND) in Q1 2026, closing a stake of 2,055 shares — an estimated $407K sold.
Simplex Trading first reported a position in LGND in Q3 2015 and held it in 22 quarters. The position peaked at $669K in Q3 2018. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.
- Simplex Trading reported no remaining Ligand Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
- Simplex Trading sold 2,055 Ligand Pharmaceuticals shares in Q1 2026, an estimated $407K.
- Simplex Trading first reported a position in Ligand Pharmaceuticals in Q3 2015 and held it in 22 quarters.
- Simplex Trading's Ligand Pharmaceuticals position peaked at $669K in Q3 2018.
- 357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.